News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,811 Results
Type
Article (88207)
Company Profile (823)
Press Release (784760)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233356)
Career Advice (4152)
Deals (39899)
Drug Delivery (158)
Drug Development (91484)
Employer Resources (205)
FDA (18445)
Job Trends (17442)
News (398152)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (166)
Alliances (56982)
ALS (193)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (381)
Approvals (18644)
Artificial intelligence (688)
Autoimmune disease (206)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (70)
Breast cancer (697)
Cancer (5374)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77471)
Collaboration (1974)
Company closure (6)
Compensation (1257)
Complete response letters (83)
COVID-19 (3005)
CRISPR (110)
C-suite (978)
Cystic fibrosis (157)
Data (6745)
Decentralized trials (2)
Denatured (77)
Depression (166)
Diabetes (556)
Diagnostics (7335)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (335)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (261)
Earnings (100829)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135960)
Executive appointments (1076)
FDA (21832)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1660)
Gene editing (234)
Generative AI (71)
Gene therapy (724)
GLP-1 (1172)
Government (5486)
Grass and pollen (8)
Guidances (389)
Healthcare (20985)
HIV (76)
Huntington's disease (56)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (77)
Indications (135)
Infectious disease (3326)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (268)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (718)
Lymphoma (397)
Machine learning (49)
Management (66)
Manufacturing (933)
MASH (186)
Medical device (15100)
Medtech (15168)
Mergers & acquisitions (23054)
Metabolic disorders (1494)
mRNA (202)
Multiple sclerosis (180)
NASH (23)
Neurodegenerative disease (391)
Neuropsychiatric disorders (110)
Neuroscience (3269)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (732)
Opinion (350)
Ovarian cancer (177)
Pain (236)
Pancreatic cancer (254)
Parkinson's disease (323)
Partnered (39)
Patents (550)
Patient recruitment (559)
Peanut (65)
People (67197)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23935)
Phase 2 (33618)
Phase 3 (25325)
Pipeline (6239)
Policy (360)
Postmarket research (3554)
Preclinical (10732)
Press Release (72)
Prostate cancer (273)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1028)
Real estate (7445)
Recruiting (81)
Regulatory (29388)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1195)
Venture capital (103)
Weight loss (498)
Women's health (107)
Worklife (23)
Date
Today (36)
Last 7 days (751)
Last 30 days (3038)
Last 365 days (32727)
2026 (6127)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51715)
Australia (9086)
California (12293)
Canada (3499)
China (1241)
Colorado (519)
Connecticut (537)
Delaware (365)
Europe (119020)
Florida (1825)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1027)
India (82)
Indiana (576)
Iowa (24)
Japan (472)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1524)
Massachusetts (9031)
Michigan (381)
Minnesota (695)
Mississippi (7)
Missouri (146)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3308)
New Mexico (33)
New York (3238)
North Carolina (1691)
North Dakota (10)
Northern California (5951)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2449)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4767)
Tennessee (194)
Texas (1939)
United States (44238)
Utah (370)
Vermont (1)
Virginia (310)
Washington D.C. (88)
Washington State (1017)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,811 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer
March 9, 2026
·
7 min read
Press Releases
Dyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
March 9, 2026
·
9 min read
Press Releases
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
March 9, 2026
·
9 min read
Press Releases
Dianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
March 9, 2026
·
1 min read
Press Releases
Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
March 9, 2026
·
1 min read
Press Releases
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
March 9, 2026
·
3 min read
Press Releases
U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
March 9, 2026
·
18 min read
Press Releases
U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China
March 9, 2026
·
1 min read
Press Releases
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
March 9, 2026
·
7 min read
Press Releases
AIM ImmunoTech Announces Closing of its Rights Offering
March 9, 2026
·
4 min read
1 of 87,382
Next
